AbbVie | ABBV - Assets

Stock Price
231.50
Daily Change
4.00 1.76%
Monthly
4.33%
Yearly
20.03%
Q1 Forecast
216.57

AbbVie reported $133.9B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
AbbVie USD 133.9B 3.28B Sep/2025
Abbott USD 84.18B 182M Sep/2025
ALKERMES USD 2.33B 76.7M Sep/2025
Amgen USD 90.59B 445M Dec/2025
AstraZeneca USD 114.07B 382M Dec/2025
Biogen USD 29.44B 232M Dec/2025
BioMarin Pharmaceutical USD 7.61B 158.53M Sep/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Coherus Biosciences USD 516.52M 77.05M Sep/2025
Eisai JPY 1.49T 48.22B Dec/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
Gilead Sciences USD 59.02B 490M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
J&J USD 199.21B 6.39B Dec/2025
Medtronic USD 90.97B 708M Jun/2025
Merck USD 129.55B 12.02B Sep/2025
Neurocrine Biosciences USD 4.63B 365.8M Dec/2025
Novartis USD 107.29B 2.89B Sep/2025
Pacira USD 1.3B 239.68M Sep/2025
Perrigo USD 10.08B 10.1M Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
UCB EUR 17.35B 1.72B Dec/2024
Ultragenyx Pharmaceutical USD 1.53B 341.56M Dec/2025
United Therapeutics USD 7.35B 556.9M Sep/2025
Vertex Pharmaceuticals USD 25.64B 780.7M Dec/2025
Zoetis USD 15.47B 308M Dec/2025